Lee, Y.-M.; Jeon, M.J.; Kim, W.W.; Sung, T.-Y.; Chung, K.-W.; Shong, Y.K.; Hong, S.J.
Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy. J. Clin. Med. 2019, 8, 1279.
https://doi.org/10.3390/jcm8091279
AMA Style
Lee Y-M, Jeon MJ, Kim WW, Sung T-Y, Chung K-W, Shong YK, Hong SJ.
Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy. Journal of Clinical Medicine. 2019; 8(9):1279.
https://doi.org/10.3390/jcm8091279
Chicago/Turabian Style
Lee, Yu-Mi, Min Ji Jeon, Won Woong Kim, Tae-Yon Sung, Ki-Wook Chung, Young Kee Shong, and Suck Joon Hong.
2019. "Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy" Journal of Clinical Medicine 8, no. 9: 1279.
https://doi.org/10.3390/jcm8091279
APA Style
Lee, Y. -M., Jeon, M. J., Kim, W. W., Sung, T. -Y., Chung, K. -W., Shong, Y. K., & Hong, S. J.
(2019). Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy. Journal of Clinical Medicine, 8(9), 1279.
https://doi.org/10.3390/jcm8091279